Cardiac Guidance vs AI-CVD
AI Verdict
Choose Cardiac Guidance if…
Choose Cardiac Guidance if your primary objective is to empower healthcare professionals, including those without extensive sonography experience, to acquire diagnostic-quality cardiac ultrasound images directly at the point of care. This tool is ideal for situations requiring immediate cardiac assessment and aims to democratize access to critical echocardiographic evaluations through real-time AI guidance and automated image capture.
View Cardiac Guidance →Choose AI-CVD if…
Choose AI-CVD if your focus is on opportunistically screening for cardiovascular and multisystem diseases by analyzing existing chest and abdominal CT scans, without the need for additional imaging or patient exposure. This platform is best suited for leveraging retrospective CT data to identify hidden health risks through automated quantitative measurements, such as coronary artery calcium scoring and cardiac chamber volumetry, thereby enhancing early disease detection programs.
View AI-CVD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiac Guidance | AI-CVD |
|---|---|---|
| Deployment | Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care. | Unknown |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiac GuidanceCardiac Guidance (Tool A) is designed for high usability, offering real-time AI guidance, turn-by-turn probe movement instructions, and automated quality assessment to empower non-expert ultrasound users to acquire diagnostic-quality images. This directly enhances user interaction and skill augmentation for a complex manual task. AI-CVD (Tool B) focuses on passive analysis of existing CT scans, which minimizes workflow disruption but doesn't offer direct interactive guidance for new data acquisition.
Clinical Value
AI-CVDAI-CVD (Tool B) offers broad clinical value through opportunistic screening for a wide range of cardiovascular and multisystem diseases (e.g., CAC scoring, valve calcification, cardiac chamber volumetry, epicardial fat, osteoporosis, liver steatosis, diabetes) from existing CT scans, enabling early detection of hidden health risks without additional procedures. Cardiac Guidance (Tool A) primarily enhances the quality and accessibility of new cardiac ultrasound image acquisition and interpretation, including EF calculation, which is valuable but more focused on a specific diagnostic procedure.
Pricing & Value
TieBoth Cardiac Guidance (Tool A) and AI-CVD (Tool B) require contacting the vendor for pricing information. Without transparent pricing details for either tool, it is impossible to conduct a head-to-head comparison of their value proposition.
Enterprise Readiness
Cardiac GuidanceCardiac Guidance (Tool A) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), alongside its FDA clearance and integration with compatible ultrasound systems. AI-CVD (Tool B) states 'likely' for HIPAA compliance and BAA, which is less definitive for enterprise adoption, although it is also FDA-cleared and cloud-deployed.
Innovation
Cardiac GuidanceCardiac Guidance (Tool A) is recognized as the first and only FDA-cleared AI-guided ultrasound acquisition software, fundamentally democratizing cardiac ultrasound by enabling non-expert healthcare professionals to acquire diagnostic-quality images through real-time guidance. While AI-CVD (Tool B) is innovative in its comprehensive opportunistic screening from existing CT scans, Tool A's direct impact on the *process* of image acquisition and skill augmentation represents a more disruptive innovation in diagnostic accessibility.
Support & Docs
Cardiac GuidanceCaption Health (Tool A) explicitly mentions providing resources, training, and implementation support for clinicians and partners, including educational materials. HeartLung Corporation (Tool B) has less prominent information regarding specific customer support or documentation on its website, making Tool A appear to have a more robust support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiac Guidance | AI-CVD |
|---|---|---|
| Name | Cardiac Guidance | AI-CVD |
| Company | Caption Health | HeartLung Corporation |
| Description | FDA-cleared AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments. | FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. |
| Primary Imaging Modality | Ultrasound | CT Scans |
| Key Features (Cardiac) | Real-time AI guidance for cardiac ultrasound image acquisition, automated quality assessment, auto-capture of diagnostic-quality images, automated left ventricular ejection fraction (EF) calculation, support for 10 standard echocardiographic views. | Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing. |
| Target User/Workflow | Non-expert ultrasound users at the point of care for cardiac assessments. | Opportunistic screening from existing chest and abdominal CT scans with no additional imaging, radiation, contrast, or workflow disruption. |
Videos
Demos, reviews, and walkthroughs featuring Cardiac Guidance and AI-CVD.